{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T06:52:57Z","timestamp":1759042377141},"reference-count":40,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["psy-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.psychres.2013.04.009","type":"journal-article","created":{"date-parts":[[2013,5,14]],"date-time":"2013-05-14T23:39:25Z","timestamp":1368574765000},"page":"401-405","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Short-term remission in schizophrenia as a combination of several outcome measures"],"prefix":"10.1016","volume":"209","author":[{"given":"Paolo","family":"Stratta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2013.04.009_bib1","series-title":"Diagnostic and Statistical Manual of Mental Disorders, fourth edition: DSM-IV","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.psychres.2013.04.009_bib2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2013.04.009_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.schres.2011.07.031","article-title":"Analysis of efficacy and side effects in CATIE demonstrates drug responses subgroups and potential for personalized medicine","volume":"132","author":"Clark","year":"2011","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2013.04.009_bib4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.schres.2010.05.027","article-title":"Quality of life in patients who have remitted from their first episode of psychosis","volume":"121","author":"Cotton","year":"2010","journal-title":"Schizophrenia Research"},{"issue":"1","key":"10.1016\/j.psychres.2013.04.009_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/schbul\/sbm122","article-title":"Remission and recovery in schizophrenia: practitioner and patient perspectives","volume":"34","author":"Davidson","year":"2008","journal-title":"Schizophrenia Bulletin"},{"issue":"6","key":"10.1016\/j.psychres.2013.04.009_bib6","doi-asserted-by":"crossref","first-page":"e36889","DOI":"10.1371\/journal.pone.0036889","article-title":"Changes in body weight and psychotropic drugs: a systematic synthesis of the literature","volume":"7","author":"Dent","year":"2012","journal-title":"Plos one"},{"issue":"5","key":"10.1016\/j.psychres.2013.04.009_bib7","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1210\/en.2007-1722","article-title":"Obesity and hypertriglyceridemia produce cognitive impairment","volume":"149","author":"Farr","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.psychres.2013.04.009_bib8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.arr.2010.04.007","article-title":"Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease","volume":"9","author":"Frisardi","year":"2010","journal-title":"Ageing Research Reviews"},{"key":"10.1016\/j.psychres.2013.04.009_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-244X-6-45","article-title":"Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial","volume":"6","author":"Gharabawi","year":"2006","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2013.04.009_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1601-5215.2011.00527.x","article-title":"Association between metabolic syndrome and cognitive decline: a systematic review of prospective population based studies","volume":"23","author":"Hao","year":"2011","journal-title":"Acta Neuropsychiatrica"},{"key":"10.1016\/j.psychres.2013.04.009_bib11","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1192\/bjp.178.6.506","article-title":"Recovery from psychotic illness: a 15- and 25-year international follow-up study","volume":"178","author":"Harrison","year":"2001","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2013.04.009_bib12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000296071","article-title":"Metabolic syndrome is associated with learning and recall impairment in middle age","volume":"29","author":"Hassenstab","year":"2010","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1016\/j.psychres.2013.04.009_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S0033291700050182","article-title":"A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity","volume":"13","author":"Hogan","year":"1983","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.psychres.2013.04.009_bib14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2165\/00023210-200721090-00001","article-title":"Conceptual and methodological issues in the design of clinical trials of antipsychotics for the treatment of schizophrenia","volume":"21","author":"Honer","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2013.04.009_bib15","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1176\/appi.ajp.160.6.1125","article-title":"Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic","volume":"160","author":"Kane","year":"2003","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2013.04.009_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.psychres.2013.04.009_bib17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.eurpsy.2009.09.001","article-title":"Establishing remission and good clinical functioning in schizophrenia: predictors of best outcome with long-term risperidone long-acting injectable treatment","volume":"25","author":"Lambert","year":"2010","journal-title":"European Psychiatry"},{"key":"10.1016\/j.psychres.2013.04.009_bib18","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.4088\/JCP.v67n1104","article-title":"Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia","volume":"6","author":"Lambert","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl 2","key":"10.1016\/j.psychres.2013.04.009_bib19","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia","volume":"161","author":"Lehman","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2013.04.009_bib20","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.psychres.2013.04.009_bib21","first-page":"1S","article-title":"The relationship between metabolic syndrome (mets) and neurocognitive functioning in patients with schizophrenia","volume":"71","author":"Lindenmayer","year":"2012","journal-title":"Biological Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.psychres.2013.04.009_bib22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.schres.2010.10.024","article-title":"Clinical global impression of improvement (CGI-I) as a valid proxy measure for remission in schizophrenia: analyses of ziprasidone clinical study data","volume":"126","author":"Masand","year":"2011","journal-title":"Schizophrenia Research"},{"issue":"Suppl 3","key":"10.1016\/j.psychres.2013.04.009_bib23","first-page":"S133","article-title":"A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables","volume":"10","author":"Naber","year":"1995","journal-title":"International Journal of Psychopharmacology"},{"key":"10.1016\/j.psychres.2013.04.009_bib24","series-title":"The National Adult Reading Test (NART): Test Manual","author":"Nelson","year":"1982"},{"issue":"Suppl 1","key":"10.1016\/j.psychres.2013.04.009_bib25","first-page":"1","article-title":"Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2013.04.009_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1192\/bjp.bp.111.104414","article-title":"Symptomatic remission in psychosis and real-life functioning","volume":"201","author":"Oorschot","year":"2012","journal-title":"British Journal of Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2013.04.009_bib27","first-page":"107","article-title":"Valutazione dell\u2019intelligenza premorbosa in pazienti con disturbo schizofrenico","volume":"28","author":"Prosperini","year":"2001","journal-title":"Giornale Italiano di Psicologia"},{"key":"10.1016\/j.psychres.2013.04.009_bib28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","article-title":"Validity of the trail making test as an indicator of organic brain disease","volume":"8","author":"Reitan","year":"1958","journal-title":"Perceptual and Psychomotor Skills"},{"key":"10.1016\/j.psychres.2013.04.009_bib29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1176\/appi.ajp.161.3.473","article-title":"Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder","volume":"161","author":"Robinson","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2013.04.009_bib30","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/hup.1067","article-title":"Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder","volume":"24","author":"Rossi","year":"2009","journal-title":"Human Psychopharmacology"},{"key":"10.1016\/j.psychres.2013.04.009_bib31","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/YIC.0b013e3282f94905","article-title":"Assessment of clinical and metabolic status, and subjective well-being, in schizophrenic patients switched from typical and atypical antipsychotics to ziprasidone","volume":"23","author":"Rossi","year":"2008","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1016\/j.psychres.2013.04.009_bib32","article-title":"T.I.B. test di intelligenza breve per la valutazione del quoziente intellettivo attuale e pre-morboso","volume":"1","author":"Sartori","year":"1997","journal-title":"Professione Psicologo."},{"issue":"1","key":"10.1016\/j.psychres.2013.04.009_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neulet.2009.06.071","article-title":"Mental slowness and executive dysfunction in patients with metabolic syndrome","volume":"462","author":"Segura","year":"2009","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.psychres.2013.04.009_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.psychres.2013.04.009_bib35","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1467-789X.2011.00920.x","article-title":"A review of the association between obesity and cognitive function across the lifespan: implications for novel approaches to prevention and treatment","volume":"12","author":"Smith","year":"2011","journal-title":"Obesity Reviews"},{"key":"10.1016\/j.psychres.2013.04.009_bib36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1600-0447.2005.00659.x","article-title":"Standardized remission criteria in schizophrenia","volume":"113","author":"van Os","year":"2006","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.psychres.2013.04.009_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2377-5-23","article-title":"The effect of body mass index on global brain volume in middle-aged adults: a cross sectional study","volume":"5","author":"Ward","year":"2005","journal-title":"BMC Neurology"},{"issue":"4","key":"10.1016\/j.psychres.2013.04.009_bib38","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1073\/pnas.0808587106","article-title":"Caloric restriction improves memory in elderly humans","volume":"106","author":"Witte","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/j.psychres.2013.04.009_bib39","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/13651500903531365","article-title":"Remission, prediction and stability of symptoms in schizophrenia: a naturalistic 12-month follow-up study","volume":"14","author":"Wolter","year":"2010","journal-title":"International Journal of Psychiatry in Clinical Practice"},{"issue":"4","key":"10.1016\/j.psychres.2013.04.009_bib40","doi-asserted-by":"crossref","first-page":"e856","DOI":"10.1542\/peds.2012-0324","article-title":"Obesity and metabolic syndrome and functional and structural brain impairments in adolescence","volume":"130","author":"Yau","year":"2012","journal-title":"Pediatrics"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178113001972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178113001972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T21:20:42Z","timestamp":1539638442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178113001972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0165178113001972"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2013.04.009","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-term remission in schizophrenia as a combination of several outcome measures","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2013.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}